Kommalapati A, Tella SH, Go RS, Goyal G. Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma. Leuk Lymphoma. 2019;60:553–5.

PubMed  Google Scholar 

Skala SL, Lucas DR, Dewar R. Histiocytic sarcoma: review, discussion of transformation from B-cell lymphoma, and differential diagnosis. Arch Pathol Lab Med. 2018;142:1322–9.

CAS  PubMed  Google Scholar 

Deepa G, Kamal V, Nandini V, Noaline S, Pande SC. Histiocytic sarcoma of the lymph node: a rare and aggressive hematolymphoid malignancy. Hematol Transfus Cell Ther. 2020;42:184–7.

PubMed  Google Scholar 

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.

CAS  PubMed  PubMed Central  Google Scholar 

Feldman AL, Minniti C, Santi M, Downing JR, Raffeld M, Jaffe ES. Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol. 2004;5:248–50.

PubMed  Google Scholar 

Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, et al. Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Mod Pathol. 2011;24:1421–32.

CAS  PubMed  PubMed Central  Google Scholar 

Brunner P, Rufle A, Dirnhofer S, Lohri A, Willi N, Cathomas G, et al. Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor. Leukemia. 2014;28:1937–40.

CAS  PubMed  Google Scholar 

Feldman AL, Arber DA, Pittaluga S, Martinez A, Burke JS, Raffeld M, et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008;111:5433–9.

CAS  PubMed  PubMed Central  Google Scholar 

Fernandez-Pol S, Bangs CD, Cherry A, Arber DA, Gratzinger D. Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma. Hum Pathol. 2016;55:39–43.

CAS  PubMed  Google Scholar 

Haebe S, Keay W, Alig S, Mohr AW, Martin LK, Heide M, et al. The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells. Br J Haematol. 2022;196:1381–7.

CAS  PubMed  Google Scholar 

Zhao C, Pan Z. Histiocytic/dendritic cell neoplasms: primary and transdifferentiated. In: Wang E, Lagoo AS, editors. Practical lymph node and bone marrow pathology: frequently asked questions. Cham: Springer International Publishing; 2020. pp. 345–54.

Farris M, Hughes RT, Lamar Z, Soike MH, Menke JR, Ohgami RS, et al. Histiocytic sarcoma associated with follicular lymphoma: evidence for dramatic response with rituximab and bendamustine alone and a review of the literature. Clin Lymphoma Myeloma Leuk. 2019;19:e1–8.

PubMed  Google Scholar 

Pan Z, Xu ML. Histiocytic and dendritic cell neoplasms. Surg Pathol Clin. 2019;12:805–29.

PubMed  Google Scholar 

Hung YP, Qian X. Histiocytic sarcoma. Arch Pathol Lab Med. 2019;144:650–4.

PubMed  Google Scholar 

Ravindran A, Dasari S, Ruan GJ, Artymiuk CJ, He R, Viswanatha DS, et al. Malignant histiocytosis comprises a phenotypic spectrum that parallels the lineage differentiation of monocytes, macrophages, dendritic cells, and langerhans cells. Mod Pathol. 2023;36:100268.

CAS  PubMed  Google Scholar 

Durham BH, Hershkovitz-Rokah O, Abdel-Wahab O, Yabe M, Chung YR, Itchaki G, et al. Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms. Blood Adv. 2023;7:7319–28.

CAS  PubMed  PubMed Central  Google Scholar 

Haebe S, Day G, Czerwinski DK, Sathe A, Grimes SM, Chen T, et al. Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B-cell receptor. Blood. 2023;142:2296–304.

CAS  PubMed  PubMed Central  Google Scholar 

Aibar S, González-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14:1083–6.

CAS  PubMed  PubMed Central  Google Scholar 

Nutt SL, Metcalf D, D’Amico A, Polli M, Wu L. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J Exp Med. 2005;201:221–31.

CAS  PubMed  PubMed Central  Google Scholar 

Xiu Y, Dong Q, Fu L, Bossler A, Tang X, Boyce B, et al. Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion. Blood. 2020;135:108–20.

PubMed  PubMed Central  Google Scholar 

Susan Joy Philip D, Sherief A, Narayanan G, Nair SG, Av J. Histiocytic sarcoma: clinical features and outcomes of patients treated at a tertiary cancer care center. Cureus. 2022;14:e25814.

PubMed  PubMed Central  Google Scholar 

Gounder MM, Solit DB, Tap WD. Trametinib in histiocytic sarcoma with an activating MAP2K1 (MEK1) mutation. N Engl J Med. 2018;378:1945–7.

PubMed  PubMed Central  Google Scholar 

Diamond EL, Durham BH, Ulaner GA, Drill E, Buthorn J, Ki M, et al. Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature. 2019;567:521–4.

CAS  PubMed  PubMed Central  Google Scholar 

Haebe S, Shree T, Sathe A, Day G, Czerwinski DK, Grimes SM, et al. Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma. Blood. 2021;137:2869–80.

CAS  PubMed  PubMed Central  Google Scholar 

Miranda MB, Xu H, Torchia JA, Johnson DE. Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway. Leuk Res. 2005;29:1293–306.

CAS  PubMed  Google Scholar 

Goyal G, Abeykoon JP, Bennani NN, Liu MC, Shah MV, Go RS. Molecular alterations in adult histiocytic neoplasms. Blood. 2019;134:2975.

Google Scholar 

Zhao Y, Deng Y, Jiang Y, Zheng W, Tan Y, Yang Z, et al. Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis. Front Immunol. 2023;14:1127599.

CAS  PubMed  PubMed Central  Google Scholar